Josh Yellson

Bachelor of Medicine and Bachelor of Science,  The Johns Hopkins Hospital 

Location: United States

Consulting Services

Journal Manuscript Career Advice and Mentoring Data Science-Bioinformatics Biostatistics

Areas Of Interest

Methyltransferases, tRNA Cytochrome P 450 CYP19 Hemophilias, Classic Patient Handovers Complement Component 4 Galactoprotein b3 Dihydergot Disease, Hammond's protein, ELAVL2 Hepatocyte Nuclear Factor 3alpha Tadzhikistan Phases, Early Placental Hybridization, Introgressive Interleukin-4 Receptor alpha Chain Dorsomedial Thalamic Nucleus Stage-Specific Embryonic Antigen Mammographic Breast Densities Immune Globulin, Rh Dehydrobenzperidol Social Breakdown Syndrome

Professional Narrative

Dr. Josh Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Executive Director, Harvard Med 2005
Assistant Professor, Harvard Med 1992

Education

Doctor of medicine, Harvard Medical School 1988
Bachelor of science in nursing, Weill Medical College 1987

Referees

Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02